Moneycontrol
HomeNewsIndiaOmicron's XBB most prevalent sub-lineage circulating all over India: INSACOG bulletin
Trending Topics

Omicron's XBB most prevalent sub-lineage circulating all over India: INSACOG bulletin

According to the bulletin, BA.2.75 and BA.2.10 were also circulating but in lesser extent.

January 02, 2023 / 23:02 IST
Story continues below Advertisement

Omicron | Representative image

COVID-19 variant Omicron and its sub-lineages continue to be the dominant variant in India with 'XBB' being the most prevalent sub-lineage circulating all over the country, the INSACOG said in its bulletin.

The Indian SARS-CoV-2 Genomics Consortium (INSACOG) bulletin was released on Monday.

Story continues below Advertisement

According to the bulletin, BA.2.75 and BA.2.10 were also circulating but in lesser extent.

"Especially, in north-east India, BA.2.75 is the prevalent sub-lineage. However, any increase in disease severity or hospitalisation has not been observed over this period," it said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show